• Two IP protected products, Mentanine® and Mentabinol®, made through cannabinoid molecules to address mental health issues. The products are ready for commercialization as non-Rx (non-prescription drugs) products in Canada, and the U.S.
      • To read more about CanaQuest Medical Corp. click below on downloads

Visit CanaQuest Medical Corp. page for more research, discussion boards and to like, and share.

Are you enjoying the highlights?

Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.

Already a member? Sign In

Investors are also interested in: